Table III.
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
Parameters | Hazard ratio | 95% CI | P-value | Hazard ratio | 95% CI | P-value |
Age, years | ||||||
≤64 | 1.138 | 0.516-2.511 | 0.749 | |||
>64 | ||||||
Menopausal status | ||||||
Premenopausal | 2.209 | 0.515-9.478 | 0.286 | |||
Postmenopausal | ||||||
Degree of progression | ||||||
Bone or soft tissue | 0.605 | 0.271-1.355 | 0.222 | |||
Visceral metastases | ||||||
TILs | ||||||
High | 0.527 | 0.208-1.339 | 0.178 | |||
Low | ||||||
Ki67, % | ||||||
≤14 | 1.049 | 0.391-2.815 | 0.925 | 1.578 | 0.540-4.610 | 0.405 |
>14 | ||||||
Response rate | ||||||
ORR | 0.179 | 0.072-0.443 | <0.001 | 0.048 | 0.011-0.199 | <0.001 |
Non-ORR | ||||||
LPBC | ||||||
Yes | 0.158 | 0.037-0.680 | 0.013 | 0.058 | 0.010-0.333 | 0.001 |
No |
CI, confidence interval; TILs, tumor-infiltrating lymphocytes; ORR, objective response rate; LPBC, lymphocyte-predominant breast cancer.